Stockreport

Revolution Medicines Inc (RVMD) Q4 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF This article first appeared on GuruFocus Cash and Investments: $2.03 billion at the end of Q4 2025. R&D Expenses: $294.9 million for Q4 2025, up from $188.1 million [Read more]